Merck | MRK - Sales Revenues

Stock Price
107.60
Daily Change
0.20 0.19%
Monthly
-14.77%
Yearly
-15.01%
Q2 Forecast
101.98

Merck reported EUR5.25B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Adidas EUR 6.08B 550M Dec/2025
Adyen EUR 1.09B 558.7M Jun/2025
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.7B 110M Dec/2025
Amadeus IT EUR 1.62B 18.3M Dec/2025
Amarin USD 49.22M 451K Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
BASF EUR 14.03B 300M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Beiersdorf EUR 2.31B 40M Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Danone EUR 6.68B 200M Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 1.06B 36M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Henkel EUR 10.09B 4.93B Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Infineon EUR 3.66B 280M Dec/2025
Linde USD 8.76B 149M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
UCB EUR 4.25B 764M Dec/2025